カテゴリ： QYResearch, 世界, 医療/バイオ

腫瘍随伴性天疱瘡治療の世界市場2023年：皮下、静脈内、経口

■ 英語タイトル：Global Paraneoplastic Pemphigus Treatment Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA3854）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA3854
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：89
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[腫瘍随伴性天疱瘡治療の世界市場2023年：皮下、静脈内、経口]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査資料は腫瘍随伴性天疱瘡治療のグローバル市場について調査・分析し、世界の腫瘍随伴性天疱瘡治療市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（皮下、静脈内、経口）、用途別セグメント分析（病院薬局、皮膚科クリニック、小売店薬局、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Novartis Pharmaceuticals、Sanofi S.A.、Hoffmann-La-Roche、Pfizer Inc.、GlaxoSmithKline LLC、Teva Pharmaceuticals、Principia Biopharma, Inc.、Biogen, Inc.、Argenx、Teligent Inc.、Syntimmune、Almirallなどが含まれています。腫瘍随伴性天疱瘡治療のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、腫瘍随伴性天疱瘡治療市場規模を算出する際に考慮しました。

・腫瘍随伴性天疱瘡治療市場の概要
- 腫瘍随伴性天疱瘡治療の種類別セグメント
- 世界の腫瘍随伴性天疱瘡治療市場規模：タイプ別分析（皮下、静脈内、経口）
- 腫瘍随伴性天疱瘡治療の用途別セグメント
- 世界の腫瘍随伴性天疱瘡治療市場規模：用途別分析（病院薬局、皮膚科クリニック、小売店薬局、その他）
- 世界の腫瘍随伴性天疱瘡治療市場規模予測（2018年-2029年）

・腫瘍随伴性天疱瘡治療市場の成長トレンド
- 腫瘍随伴性天疱瘡治療の地域別市場規模（2018年-2029年）
- 腫瘍随伴性天疱瘡治療市場ダイナミクス
- 腫瘍随伴性天疱瘡治療の業界動向
- 腫瘍随伴性天疱瘡治療市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・種類別セグメント：皮下、静脈内、経口
- 世界の腫瘍随伴性天疱瘡治療のタイプ別市場規模（2018年-2023年）
- 世界の腫瘍随伴性天疱瘡治療のタイプ別市場規模（2024年-2029年）

・用途別セグメント：病院薬局、皮膚科クリニック、小売店薬局、その他
- 世界の腫瘍随伴性天疱瘡治療の用途別市場規模（2018年-2023年）
- 世界の腫瘍随伴性天疱瘡治療の用途別市場規模（2024年-2029年）

・腫瘍随伴性天疱瘡治療の地域別市場規模
- 北米の腫瘍随伴性天疱瘡治療市場規模（2018年-2029年）
- 米国の腫瘍随伴性天疱瘡治療市場規模（2018年-2029年）
- ヨーロッパの腫瘍随伴性天疱瘡治療市場規模（2018年-2029年）
- アジア太平洋の腫瘍随伴性天疱瘡治療市場規模（2018年-2029年）
- 中国の腫瘍随伴性天疱瘡治療市場規模（2018年-2029年）
- 日本の腫瘍随伴性天疱瘡治療市場規模（2018年-2029年）
- 韓国の腫瘍随伴性天疱瘡治療市場規模（2018年-2029年）
- インドの腫瘍随伴性天疱瘡治療市場規模（2018年-2029年）
- オーストラリアの腫瘍随伴性天疱瘡治療市場規模（2018年-2029年）
- 中南米の腫瘍随伴性天疱瘡治療市場規模（2018年-2029年）
- 中東・アフリカの腫瘍随伴性天疱瘡治療市場規模（2018年-2029年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
Novartis Pharmaceuticals、Sanofi S.A.、Hoffmann-La-Roche、Pfizer Inc.、GlaxoSmithKline LLC、Teva Pharmaceuticals、Principia Biopharma, Inc.、Biogen, Inc.、Argenx、Teligent Inc.、Syntimmune、Almirall

・アナリストの観点/結論

・調査手法と情報源

Highlights
The global Paraneoplastic Pemphigus Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Paraneoplastic Pemphigus Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Paraneoplastic Pemphigus Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Paraneoplastic Pemphigus Treatment in Hospital Pharmacies is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Paraneoplastic Pemphigus Treatment include Novartis Pharmaceuticals, Sanofi S.A., Hoffmann-La-Roche, Pfizer Inc., GlaxoSmithKline LLC, Teva Pharmaceuticals, Principia Biopharma, Inc., Biogen, Inc. and Argenx, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Paraneoplastic Pemphigus Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Paraneoplastic Pemphigus Treatment.
The Paraneoplastic Pemphigus Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Paraneoplastic Pemphigus Treatment market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Paraneoplastic Pemphigus Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Novartis Pharmaceuticals
Sanofi S.A.
Hoffmann-La-Roche
Pfizer Inc.
GlaxoSmithKline LLC
Teva Pharmaceuticals
Principia Biopharma, Inc.
Biogen, Inc.
Argenx
Teligent Inc.
Syntimmune
Almirall
Segment by Type
Subcutaneous
Intravenous
Oral
Segment by Application
Hospital Pharmacies
Dermatology Clinics
Retail Pharmacies
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Paraneoplastic Pemphigus Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Paraneoplastic Pemphigus Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Subcutaneous
1.2.3 Intravenous
1.2.4 Oral
1.3 Market by Application
1.3.1 Global Paraneoplastic Pemphigus Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacies
1.3.3 Dermatology Clinics
1.3.4 Retail Pharmacies
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Paraneoplastic Pemphigus Treatment Market Perspective (2018-2029)
2.2 Paraneoplastic Pemphigus Treatment Growth Trends by Region
2.2.1 Global Paraneoplastic Pemphigus Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Paraneoplastic Pemphigus Treatment Historic Market Size by Region (2018-2023)
2.2.3 Paraneoplastic Pemphigus Treatment Forecasted Market Size by Region (2024-2029)
2.3 Paraneoplastic Pemphigus Treatment Market Dynamics
2.3.1 Paraneoplastic Pemphigus Treatment Industry Trends
2.3.2 Paraneoplastic Pemphigus Treatment Market Drivers
2.3.3 Paraneoplastic Pemphigus Treatment Market Challenges
2.3.4 Paraneoplastic Pemphigus Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Paraneoplastic Pemphigus Treatment Players by Revenue
3.1.1 Global Top Paraneoplastic Pemphigus Treatment Players by Revenue (2018-2023)
3.1.2 Global Paraneoplastic Pemphigus Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Paraneoplastic Pemphigus Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Paraneoplastic Pemphigus Treatment Revenue
3.4 Global Paraneoplastic Pemphigus Treatment Market Concentration Ratio
3.4.1 Global Paraneoplastic Pemphigus Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Paraneoplastic Pemphigus Treatment Revenue in 2022
3.5 Paraneoplastic Pemphigus Treatment Key Players Head office and Area Served
3.6 Key Players Paraneoplastic Pemphigus Treatment Product Solution and Service
3.7 Date of Enter into Paraneoplastic Pemphigus Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Paraneoplastic Pemphigus Treatment Breakdown Data by Type
4.1 Global Paraneoplastic Pemphigus Treatment Historic Market Size by Type (2018-2023)
4.2 Global Paraneoplastic Pemphigus Treatment Forecasted Market Size by Type (2024-2029)
5 Paraneoplastic Pemphigus Treatment Breakdown Data by Application
5.1 Global Paraneoplastic Pemphigus Treatment Historic Market Size by Application (2018-2023)
5.2 Global Paraneoplastic Pemphigus Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Paraneoplastic Pemphigus Treatment Market Size (2018-2029)
6.2 North America Paraneoplastic Pemphigus Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Paraneoplastic Pemphigus Treatment Market Size by Country (2018-2023)
6.4 North America Paraneoplastic Pemphigus Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Paraneoplastic Pemphigus Treatment Market Size (2018-2029)
7.2 Europe Paraneoplastic Pemphigus Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Paraneoplastic Pemphigus Treatment Market Size by Country (2018-2023)
7.4 Europe Paraneoplastic Pemphigus Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Paraneoplastic Pemphigus Treatment Market Size (2018-2029)
8.2 Asia-Pacific Paraneoplastic Pemphigus Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Paraneoplastic Pemphigus Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Paraneoplastic Pemphigus Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Paraneoplastic Pemphigus Treatment Market Size (2018-2029)
9.2 Latin America Paraneoplastic Pemphigus Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Paraneoplastic Pemphigus Treatment Market Size by Country (2018-2023)
9.4 Latin America Paraneoplastic Pemphigus Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Paraneoplastic Pemphigus Treatment Market Size (2018-2029)
10.2 Middle East & Africa Paraneoplastic Pemphigus Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Paraneoplastic Pemphigus Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Paraneoplastic Pemphigus Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis Pharmaceuticals
11.1.1 Novartis Pharmaceuticals Company Detail
11.1.2 Novartis Pharmaceuticals Business Overview
11.1.3 Novartis Pharmaceuticals Paraneoplastic Pemphigus Treatment Introduction
11.1.4 Novartis Pharmaceuticals Revenue in Paraneoplastic Pemphigus Treatment Business (2018-2023)
11.1.5 Novartis Pharmaceuticals Recent Development
11.2 Sanofi S.A.
11.2.1 Sanofi S.A. Company Detail
11.2.2 Sanofi S.A. Business Overview
11.2.3 Sanofi S.A. Paraneoplastic Pemphigus Treatment Introduction
11.2.4 Sanofi S.A. Revenue in Paraneoplastic Pemphigus Treatment Business (2018-2023)
11.2.5 Sanofi S.A. Recent Development
11.3 Hoffmann-La-Roche
11.3.1 Hoffmann-La-Roche Company Detail
11.3.2 Hoffmann-La-Roche Business Overview
11.3.3 Hoffmann-La-Roche Paraneoplastic Pemphigus Treatment Introduction
11.3.4 Hoffmann-La-Roche Revenue in Paraneoplastic Pemphigus Treatment Business (2018-2023)
11.3.5 Hoffmann-La-Roche Recent Development
11.4 Pfizer Inc.
11.4.1 Pfizer Inc. Company Detail
11.4.2 Pfizer Inc. Business Overview
11.4.3 Pfizer Inc. Paraneoplastic Pemphigus Treatment Introduction
11.4.4 Pfizer Inc. Revenue in Paraneoplastic Pemphigus Treatment Business (2018-2023)
11.4.5 Pfizer Inc. Recent Development
11.5 GlaxoSmithKline LLC
11.5.1 GlaxoSmithKline LLC Company Detail
11.5.2 GlaxoSmithKline LLC Business Overview
11.5.3 GlaxoSmithKline LLC Paraneoplastic Pemphigus Treatment Introduction
11.5.4 GlaxoSmithKline LLC Revenue in Paraneoplastic Pemphigus Treatment Business (2018-2023)
11.5.5 GlaxoSmithKline LLC Recent Development
11.6 Teva Pharmaceuticals
11.6.1 Teva Pharmaceuticals Company Detail
11.6.2 Teva Pharmaceuticals Business Overview
11.6.3 Teva Pharmaceuticals Paraneoplastic Pemphigus Treatment Introduction
11.6.4 Teva Pharmaceuticals Revenue in Paraneoplastic Pemphigus Treatment Business (2018-2023)
11.6.5 Teva Pharmaceuticals Recent Development
11.7 Principia Biopharma, Inc.
11.7.1 Principia Biopharma, Inc. Company Detail
11.7.2 Principia Biopharma, Inc. Business Overview
11.7.3 Principia Biopharma, Inc. Paraneoplastic Pemphigus Treatment Introduction
11.7.4 Principia Biopharma, Inc. Revenue in Paraneoplastic Pemphigus Treatment Business (2018-2023)
11.7.5 Principia Biopharma, Inc. Recent Development
11.8 Biogen, Inc.
11.8.1 Biogen, Inc. Company Detail
11.8.2 Biogen, Inc. Business Overview
11.8.3 Biogen, Inc. Paraneoplastic Pemphigus Treatment Introduction
11.8.4 Biogen, Inc. Revenue in Paraneoplastic Pemphigus Treatment Business (2018-2023)
11.8.5 Biogen, Inc. Recent Development
11.9 Argenx
11.9.1 Argenx Company Detail
11.9.2 Argenx Business Overview
11.9.3 Argenx Paraneoplastic Pemphigus Treatment Introduction
11.9.4 Argenx Revenue in Paraneoplastic Pemphigus Treatment Business (2018-2023)
11.9.5 Argenx Recent Development
11.10 Teligent Inc.
11.10.1 Teligent Inc. Company Detail
11.10.2 Teligent Inc. Business Overview
11.10.3 Teligent Inc. Paraneoplastic Pemphigus Treatment Introduction
11.10.4 Teligent Inc. Revenue in Paraneoplastic Pemphigus Treatment Business (2018-2023)
11.10.5 Teligent Inc. Recent Development
11.11 Syntimmune
11.11.1 Syntimmune Company Detail
11.11.2 Syntimmune Business Overview
11.11.3 Syntimmune Paraneoplastic Pemphigus Treatment Introduction
11.11.4 Syntimmune Revenue in Paraneoplastic Pemphigus Treatment Business (2018-2023)
11.11.5 Syntimmune Recent Development
11.12 Almirall
11.12.1 Almirall Company Detail
11.12.2 Almirall Business Overview
11.12.3 Almirall Paraneoplastic Pemphigus Treatment Introduction
11.12.4 Almirall Revenue in Paraneoplastic Pemphigus Treatment Business (2018-2023)
11.12.5 Almirall Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Paraneoplastic Pemphigus Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Subcutaneous
Table 3. Key Players of Intravenous
Table 4. Key Players of Oral
Table 5. Global Paraneoplastic Pemphigus Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Paraneoplastic Pemphigus Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Paraneoplastic Pemphigus Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Paraneoplastic Pemphigus Treatment Market Share by Region (2018-2023)
Table 9. Global Paraneoplastic Pemphigus Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Paraneoplastic Pemphigus Treatment Market Share by Region (2024-2029)
Table 11. Paraneoplastic Pemphigus Treatment Market Trends
Table 12. Paraneoplastic Pemphigus Treatment Market Drivers
Table 13. Paraneoplastic Pemphigus Treatment Market Challenges
Table 14. Paraneoplastic Pemphigus Treatment Market Restraints
Table 15. Global Paraneoplastic Pemphigus Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Paraneoplastic Pemphigus Treatment Market Share by Players (2018-2023)
Table 17. Global Top Paraneoplastic Pemphigus Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Paraneoplastic Pemphigus Treatment as of 2022)
Table 18. Ranking of Global Top Paraneoplastic Pemphigus Treatment Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Paraneoplastic Pemphigus Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Paraneoplastic Pemphigus Treatment Product Solution and Service
Table 22. Date of Enter into Paraneoplastic Pemphigus Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Paraneoplastic Pemphigus Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Paraneoplastic Pemphigus Treatment Revenue Market Share by Type (2018-2023)
Table 26. Global Paraneoplastic Pemphigus Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Paraneoplastic Pemphigus Treatment Revenue Market Share by Type (2024-2029)
Table 28. Global Paraneoplastic Pemphigus Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Paraneoplastic Pemphigus Treatment Revenue Market Share by Application (2018-2023)
Table 30. Global Paraneoplastic Pemphigus Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Paraneoplastic Pemphigus Treatment Revenue Market Share by Application (2024-2029)
Table 32. North America Paraneoplastic Pemphigus Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Paraneoplastic Pemphigus Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Paraneoplastic Pemphigus Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Paraneoplastic Pemphigus Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Paraneoplastic Pemphigus Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Paraneoplastic Pemphigus Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Paraneoplastic Pemphigus Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Paraneoplastic Pemphigus Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Paraneoplastic Pemphigus Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Paraneoplastic Pemphigus Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Paraneoplastic Pemphigus Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Paraneoplastic Pemphigus Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Paraneoplastic Pemphigus Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Paraneoplastic Pemphigus Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Paraneoplastic Pemphigus Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 47. Novartis Pharmaceuticals Company Detail
Table 48. Novartis Pharmaceuticals Business Overview
Table 49. Novartis Pharmaceuticals Paraneoplastic Pemphigus Treatment Product
Table 50. Novartis Pharmaceuticals Revenue in Paraneoplastic Pemphigus Treatment Business (2018-2023) & (US$ Million)
Table 51. Novartis Pharmaceuticals Recent Development
Table 52. Sanofi S.A. Company Detail
Table 53. Sanofi S.A. Business Overview
Table 54. Sanofi S.A. Paraneoplastic Pemphigus Treatment Product
Table 55. Sanofi S.A. Revenue in Paraneoplastic Pemphigus Treatment Business (2018-2023) & (US$ Million)
Table 56. Sanofi S.A. Recent Development
Table 57. Hoffmann-La-Roche Company Detail
Table 58. Hoffmann-La-Roche Business Overview
Table 59. Hoffmann-La-Roche Paraneoplastic Pemphigus Treatment Product
Table 60. Hoffmann-La-Roche Revenue in Paraneoplastic Pemphigus Treatment Business (2018-2023) & (US$ Million)
Table 61. Hoffmann-La-Roche Recent Development
Table 62. Pfizer Inc. Company Detail
Table 63. Pfizer Inc. Business Overview
Table 64. Pfizer Inc. Paraneoplastic Pemphigus Treatment Product
Table 65. Pfizer Inc. Revenue in Paraneoplastic Pemphigus Treatment Business (2018-2023) & (US$ Million)
Table 66. Pfizer Inc. Recent Development
Table 67. GlaxoSmithKline LLC Company Detail
Table 68. GlaxoSmithKline LLC Business Overview
Table 69. GlaxoSmithKline LLC Paraneoplastic Pemphigus Treatment Product
Table 70. GlaxoSmithKline LLC Revenue in Paraneoplastic Pemphigus Treatment Business (2018-2023) & (US$ Million)
Table 71. GlaxoSmithKline LLC Recent Development
Table 72. Teva Pharmaceuticals Company Detail
Table 73. Teva Pharmaceuticals Business Overview
Table 74. Teva Pharmaceuticals Paraneoplastic Pemphigus Treatment Product
Table 75. Teva Pharmaceuticals Revenue in Paraneoplastic Pemphigus Treatment Business (2018-2023) & (US$ Million)
Table 76. Teva Pharmaceuticals Recent Development
Table 77. Principia Biopharma, Inc. Company Detail
Table 78. Principia Biopharma, Inc. Business Overview
Table 79. Principia Biopharma, Inc. Paraneoplastic Pemphigus Treatment Product
Table 80. Principia Biopharma, Inc. Revenue in Paraneoplastic Pemphigus Treatment Business (2018-2023) & (US$ Million)
Table 81. Principia Biopharma, Inc. Recent Development
Table 82. Biogen, Inc. Company Detail
Table 83. Biogen, Inc. Business Overview
Table 84. Biogen, Inc. Paraneoplastic Pemphigus Treatment Product
Table 85. Biogen, Inc. Revenue in Paraneoplastic Pemphigus Treatment Business (2018-2023) & (US$ Million)
Table 86. Biogen, Inc. Recent Development
Table 87. Argenx Company Detail
Table 88. Argenx Business Overview
Table 89. Argenx Paraneoplastic Pemphigus Treatment Product
Table 90. Argenx Revenue in Paraneoplastic Pemphigus Treatment Business (2018-2023) & (US$ Million)
Table 91. Argenx Recent Development
Table 92. Teligent Inc. Company Detail
Table 93. Teligent Inc. Business Overview
Table 94. Teligent Inc. Paraneoplastic Pemphigus Treatment Product
Table 95. Teligent Inc. Revenue in Paraneoplastic Pemphigus Treatment Business (2018-2023) & (US$ Million)
Table 96. Teligent Inc. Recent Development
Table 97. Syntimmune Company Detail
Table 98. Syntimmune Business Overview
Table 99. Syntimmune Paraneoplastic Pemphigus Treatment Product
Table 100. Syntimmune Revenue in Paraneoplastic Pemphigus Treatment Business (2018-2023) & (US$ Million)
Table 101. Syntimmune Recent Development
Table 102. Almirall Company Detail
Table 103. Almirall Business Overview
Table 104. Almirall Paraneoplastic Pemphigus Treatment Product
Table 105. Almirall Revenue in Paraneoplastic Pemphigus Treatment Business (2018-2023) & (US$ Million)
Table 106. Almirall Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Paraneoplastic Pemphigus Treatment Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Paraneoplastic Pemphigus Treatment Market Share by Type: 2022 VS 2029
Figure 3. Subcutaneous Features
Figure 4. Intravenous Features
Figure 5. Oral Features
Figure 6. Global Paraneoplastic Pemphigus Treatment Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Paraneoplastic Pemphigus Treatment Market Share by Application: 2022 VS 2029
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Dermatology Clinics Case Studies
Figure 10. Retail Pharmacies Case Studies
Figure 11. Others Case Studies
Figure 12. Paraneoplastic Pemphigus Treatment Report Years Considered
Figure 13. Global Paraneoplastic Pemphigus Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Paraneoplastic Pemphigus Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Paraneoplastic Pemphigus Treatment Market Share by Region: 2022 VS 2029
Figure 16. Global Paraneoplastic Pemphigus Treatment Market Share by Players in 2022
Figure 17. Global Top Paraneoplastic Pemphigus Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Paraneoplastic Pemphigus Treatment as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Paraneoplastic Pemphigus Treatment Revenue in 2022
Figure 19. North America Paraneoplastic Pemphigus Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Paraneoplastic Pemphigus Treatment Market Share by Country (2018-2029)
Figure 21. United States Paraneoplastic Pemphigus Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Paraneoplastic Pemphigus Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Paraneoplastic Pemphigus Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Paraneoplastic Pemphigus Treatment Market Share by Country (2018-2029)
Figure 25. Germany Paraneoplastic Pemphigus Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Paraneoplastic Pemphigus Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Paraneoplastic Pemphigus Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Paraneoplastic Pemphigus Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Paraneoplastic Pemphigus Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Paraneoplastic Pemphigus Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Paraneoplastic Pemphigus Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Paraneoplastic Pemphigus Treatment Market Share by Region (2018-2029)
Figure 33. China Paraneoplastic Pemphigus Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Paraneoplastic Pemphigus Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Paraneoplastic Pemphigus Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Paraneoplastic Pemphigus Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Paraneoplastic Pemphigus Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Paraneoplastic Pemphigus Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Paraneoplastic Pemphigus Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Paraneoplastic Pemphigus Treatment Market Share by Country (2018-2029)
Figure 41. Mexico Paraneoplastic Pemphigus Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Paraneoplastic Pemphigus Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Paraneoplastic Pemphigus Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Paraneoplastic Pemphigus Treatment Market Share by Country (2018-2029)
Figure 45. Turkey Paraneoplastic Pemphigus Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Paraneoplastic Pemphigus Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Novartis Pharmaceuticals Revenue Growth Rate in Paraneoplastic Pemphigus Treatment Business (2018-2023)
Figure 48. Sanofi S.A. Revenue Growth Rate in Paraneoplastic Pemphigus Treatment Business (2018-2023)
Figure 49. Hoffmann-La-Roche Revenue Growth Rate in Paraneoplastic Pemphigus Treatment Business (2018-2023)
Figure 50. Pfizer Inc. Revenue Growth Rate in Paraneoplastic Pemphigus Treatment Business (2018-2023)
Figure 51. GlaxoSmithKline LLC Revenue Growth Rate in Paraneoplastic Pemphigus Treatment Business (2018-2023)
Figure 52. Teva Pharmaceuticals Revenue Growth Rate in Paraneoplastic Pemphigus Treatment Business (2018-2023)
Figure 53. Principia Biopharma, Inc. Revenue Growth Rate in Paraneoplastic Pemphigus Treatment Business (2018-2023)
Figure 54. Biogen, Inc. Revenue Growth Rate in Paraneoplastic Pemphigus Treatment Business (2018-2023)
Figure 55. Argenx Revenue Growth Rate in Paraneoplastic Pemphigus Treatment Business (2018-2023)
Figure 56. Teligent Inc. Revenue Growth Rate in Paraneoplastic Pemphigus Treatment Business (2018-2023)
Figure 57. Syntimmune Revenue Growth Rate in Paraneoplastic Pemphigus Treatment Business (2018-2023)
Figure 58. Almirall Revenue Growth Rate in Paraneoplastic Pemphigus Treatment Business (2018-2023)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 血液腫瘍治療の世界市場2023年：化学療法、標的療法、免疫療法、その他
  • 痔疾治療器の世界市場2023年：バンドリガー、赤外線凝固装置、肛門鏡＆内視鏡、バイポーラシステム、ドップラープローブ、その他
  • ウイルス養殖病治療の世界市場2023年：不活化ウイルスワクチン、生ウイルスワクチン
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA3854 )"腫瘍随伴性天疱瘡治療の世界市場2023年：皮下、静脈内、経口" (英文：Global Paraneoplastic Pemphigus Treatment Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。